Hence, KDM7A-DT variations in BRCA may function as a tumor suppressor or pro-oncogenic using the TP53-TP53BP1-NHEJ pathway; their functions may be categorized as genetically, epigenetically, environmentally, and cellular in origin. This evidence concerns the gene TP53 and neoplasm.